Skin Boosters Market To Witness A Significant Growth Of USD 1.96 Billion By 2030


 San Francisco, 18 March 2024: The Report Skin Boosters Market Size, Share & Trends Analysis Report By Type (Mesotherapy, Micro-needle), By Gender (Female, Male), By End-use (Dermatology Clinics, Medspa), By Region, And Segment Forecasts, 2024 - 2030

The global skin boosters market size is expected to reach USD 1.96 billion by 2030, expanding at a CAGR of 9.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. Under this procedure wherein microinjections of biocompatible compounds like hyaluronic acid, vitamins, minerals, and anti-oxidants, etc. that are naturally produced by the body are injected into the epidermis or mesoderm. Also, this simply helps aid in the hydration process, which is fundamental for a youthful glow.

Unlike dermal fillers, skin boosters are not for wrinkle reduction or augmentation, their role is to primarily hydrate the skin and promote the formation of new collagen and elastin to give the skin a firmer appearance. Factors like rising technological advancement in aesthetics, rising disposable income, increasing aesthetic consciousness, and the increasing geriatric population in the search for a natural glow are propelling the market growth. According to Galderma, over five million treatments of Restylane Skinboosters have been performed to date.

The demand is expected to propel significantly due to the fact that it provides a natural glow without distorting facial features or making them appear out of proportion. Growing social media influence, high consciousness towards aesthetic appearance, and its association with self-confidence and self-image by an individual are some of the reasons for market growth.

In the light of COVID-19, the market was hampered as the footfall of patient appointments for surgical treatments was temporarily suspended. However, since the government in many countries has allowed resuming elective aesthetic procedures the demand has been on the rise. Moreover, according to the BBC network, inquiries and appointments for many surgical and non-surgical cosmetic treatments have seen a surge following the pandemic and are thus expected to propel market growth.

Access Research Report of Skin Boosters Market https://www.grandviewresearch.com/industry-analysis/skin-boosters-market-report

Skin Boosters Market Report Highlights

  • By type, the Mesotherapy procedure held the largest market share in 2023 as the procedure has minimal downtime and the booster can be inserted deeper for effective skin rejuvenation
  • Based on gender, the female segment held the highest market share in 2023, women are more willing to undergo cosmetic treatment.
  • Medspa market held the highest market share in 2023. This is due to the fact that Medspa provides aesthetic treatments under the supervision of a licensed medical practitioner
  • North America leads the Skin Boosters market with the highest revenue share in 2023 as the region has a high awareness of such procedures and there is high availability of aesthetic professionals.

Skin Boosters Market Report Scope

Report Attribute

Details

Market size value in 2024

USD 1.17 billion

Revenue forecast in 2030

USD 1.96 billion

Growth Rate

CAGR of 9.0% from 2024 to 2030

Base year for estimation

2023

Historical data

2018 - 2022

Forecast period

2024 - 2030

List Of Key Players in the Skin Boosters Market

  • Bloomage Biotech Co., Ltd.
  • Medytox, Inc.
  • AbbVie Inc.
  • Merz Pharma
  • Galderma
  • Teoxane
  • IBSA Farmaceutici Italia Srl
  • PharmaResearch Co., Ltd.

Access Press Release of Skin Boosters Market @ https://www.grandviewresearch.com/press-release/global-skin-boosters-market

 

Comments

Popular posts from this blog

Asia Pacific PoC Diagnostics Market Growth Opportunities, Industry Analysis And Forecast: Grand View Research Inc.

Food Additives Market Size & Share Hit USD 55.53 Billion By 2022 : Grand View Research Inc.

Integration Platform as a Service Market Valuation Is Expected To Exceed USD 2.70 Billion By 2025: Grand View Research Inc.